Lexology March 13, 2024
Harris Sliwoski LLP

Table of Contents

Many people struggling with treatment-resistant depression, which does not respond to at least two types of treatment, are finally experiencing relief with intravenous ketamine therapy.

Hundreds of ketamine clinics have been popping up across the country in recent years, and researchers claim infusing or injecting the drug has the potential to treat a wide range of conditions that have been difficult to manage in the past.

The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Mental Health, Patient / Consumer, Provider
The Coalition For Student Wellbeing: Bridging Gaps In Mental Health
Loneliness: Two types, two impacts, and what they mean for mental health
Behavioral health needs better metrics — Centerstone steps up
Wellpath's behavioral health unit becomes independent company
1 system's 'no wrong door' strategy for behavioral health

Share This Article